1Dalai KM, Gollub M J, Miner TJ, et al. Management of pa- tients with malignant bowel obstruction and stage IV colorec- tal cancer[J]. J Palliat Med,2011, 14(7) :822-828.
3Yafi FA, North S, Kassouf W. First- and second-line thera- py for metastatic urothelial carcinoma of the bladder [ J ]. Curr Oncol,2011, 18( 1 ) :e25-34.
1Hussain SA,James ND.The systemic treatment of advanced and metastatic bladder cancer[J].Lancet Oncol,2003,4:489-497.
2Shrod SS,Faucette SR,Gillenwater HH,et al.Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with dvanced non-small-cell lung cancer[J].Cancer Chemother Pharmacol,2003,51:328.
3Khaled HM,Zaqhloul MS,Ghoneim M,et al.A randomized phase Ⅲ study of neoadjuvant chemotherapy for invasive bladder cancer with gemcitabine and cisplatin[J].Proc Ann Meet Am Soc Clin Oncol,2002,21:A2421.
4周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,2002.45～48.
5Krouse RS. Surgical management of malignant bowel obstruction. Surg Oncol Clin N Am, 2004, 13: 479-490.
6Davis MP, Nouneh C. Modem management of cancer-related intestinal obstruction. Curr Pain Headache Rep, 2001,5 : 257-264.
7Baines M. The pathophysiology and management of malignant intestinal obstruction. In Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1993. 311-316.
8Ripamonti C, Twycross R, Baines M, et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Caner, 2001, 9: 223-233.
9Ripamonti C, Bruera E. Palliative management of malignant bowel obstruction. Int J Cynecol Cancer, :2002, 21 : 135-143.
10Legendre H, Vanhuyse F, Caroli-Bosc FX, et al. Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction. Eur J Surg Oncol, 2001, 27: 364-367.
